The efficacy and safety of thymosin alpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial

Thymalfasin (thymosin alpha‐1; Tα1) is a 28‐amino acid polypeptide that has shown efficacy in the treatment of chronic hepatitis B virus (HBV) infection. The objective of this study was to evaluate the long‐term, dose‐related efficacy and safety of Tα1 treatment in chronic hepatitis B patients with...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of viral hepatitis 2005-05, Vol.12 (3), p.300-306
Hauptverfasser:	Iino, S., Toyota, J., Kumada, H., Kiyosawa, K., Kakumu, S., Sata, M., Suzuki, H., Martins, E. B.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adjuvants, Immunologic - administration & dosage Adult Biopsy, Needle chronic hepatitis B DNA, Viral - drug effects Dose-Response Relationship, Drug Drug Administration Schedule Female Follow-Up Studies Hepatitis B virus Hepatitis B, Chronic - drug therapy Hepatitis B, Chronic - pathology Humans Immunohistochemistry Japan Liver Function Tests Male Maximum Tolerated Dose Middle Aged Probability Risk Assessment Severity of Illness Index thymalfasin Thymosin - administration & dosage Thymosin - analogs & derivatives thymosin alpha-1 Time Factors Treatment Outcome Viral Load
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!